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Abstract— There is increasing evidence on the role of the au-
tonomic nervous system in the pathogenesis of atrial fibrillation.
Interventions targeting autonomic modulation of atrial electri-
cal activity have been shown to reduce the incidence of atrial
arrhythmias. Additionally, recent investigations have proved
that pharmacological therapies inhibiting small-conductance
calcium-activated potassium (SK) channels are able to lessen
cholinergic effects in the atria.
In this study we use computational modeling and simulation
to test individual and combined effects of SK channel block
and adrenergic stimulation in counteracting detrimental effects
induced by the parasympathetic neurotransmitter acetylcholine
(ACh) on human atrial electrophysiology. Cell and tissue models
are built that incorporate descriptions of SK channels as well
as of isoproterenol (Iso)- and ACh-mediated regulation of the
atrial action potential (AP). Three different cellular AP models,
representing a range of physiological AP shapes, are considered
and both homogeneous and heterogeneous ACh distributions in
atrial tissue are simulated.
At the cellular level, SK channel block is demonstrated to
partially revert shortening of AP duration (APD) mediated by
ACh at various doses, whereas 1 µM Iso has a variable response
depending on the AP shape. The combination of SK block and
Iso is in all cases able to take APD back to baseline levels,
recovering between 82% and 120% of the APD shortening
induced by 0.1 µM ACh. At the tissue level, SK block and
Iso alone or in combination do not exert remarkable effects
on conduction velocity, but the combination of the two is able
to notably prolong the ACh-mediated APD shortening, thus
increasing the wavelength for reentry.
In conclusion, the results from this study support the
combination of SK channel block and adrenergic stimulation as
a potential option to counteract parasympathetically-mediated
proarrhythmic effects in the human atria.
I. INTRODUCTION
Atrial fibrillation (AF) is the most common sustained
arrhythmia worldwide. Even if AF is not usually life-
threatening, it increases 3- to 5-fold the risk for stroke
and can eventually lead to heart failure. There is increasing
evidence that the autonomic nervous system (ANS) plays a
relevant role in the pathogenesis of AF [1]. The parasym-
pathetic neurotransmitter acetylcholine (ACh) activates the
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outward potassium current IKACh, which shortens the action
potential (AP) duration (APD) and hyperpolarizes the resting
membrane potential (RMP). These two effects contribute to
a reduction in the wavelength (WL), defined as the distance
traveled by the depolarization wave during the effective
refractory period (ERP), which can in turn facilitate reentrant
activity and enhance the susceptibility to the initiation and
maintenance of AF. Specifically, since WL is computed as
the product of the conduction velocity (CV) and the ERP,
ACh release can reduce WL not only by shortening APD
but also by diminishing CV. In fact, hyperpolarization of the
RMP induced by ACh leads to a reduction in the maximum
upstroke velocity (UV) of the AP [2], [3] and this can slow
CV and tissue excitability. Importantly, since ACh is rapidly
broken down at its release site by acetylcholinesterase, its
effects are largely spatially heterogeneous [4], thus addition-
ally contributing to increased AF vulnerability [1].
Based on the important role of the ANS, and particularly
of its parasympathetic branch, in modulating atrial electrical
activity, therapies targeting the ANS have been explored and
shown to reduce the incidence of atrial arrhythmias [1]. Such
therapies could be considered individually or in combination
with other pharmacological therapies. Although significant
advances in AF management have been made during the last
decades, important limitations of pharmacological treatments
in restoring sinus rhythm have been acknowledged. Recently,
in vivo and ex vivo investigations have shown that inhibi-
tion of small-conductance calcium-activated potassium (SK)
channels is able to counteract parasympathetically-induced
effects in the atria by prolonging APD and ERP [4], [5].
Since SK channels are preferentially expressed in the atria
as compared to the ventricles [1], [6], these channels could
represent a relatively atrial-selective target.
In this study the ability of different interventions, involving
adrenergic stimulation and SK channel inhibition, to restore
ACh-induced alterations in atrial electrical activity is tested.
We hypothesize that complete SK block combined with
administration of the β -adrenergic agonist isoproterenol (Iso)
can prolong the APD shortened by ACh and can bring the
AP back to its baseline state. To test this hypothesis, in silico
human atrial cell and tissue models incorporating adrenergic
and cholinergic AP modulation are developed. Simulations
are run considering both homogeneous and heterogeneous
ACh distributions in tissue. This investigation builds on a
previous study where adrenergic, cholinergic and SK channel
block effects on human atrial myocytes were computationally
assessed and compared with experimental evidence [15].
II. METHODS
A. Human atrial cell models
The Courtemanche [7] and the Skibsbye [8] human atrial
computational AP models were used. For the Courtemanche
model, two variants representing two different AP shapes
were considered [7]. The default Courtemanche model, de-
noted by Courtemanche S, presents a spike and dome shape,
whereas the other variant obtained by decreasing the maxi-
mal conductance of Ito by 70%, denoted by Courtemanche
R, presents a rectangular shape.
In both Courtemanche R and S models, parasympa-
thetic effects were described by including an acetylcholine-
activated potassium current, IKACh, as defined in [9] with the
updates proposed in [10]. In the Skibsbye model, IKACh was
described as proposed in [11].
In all AP models, sympathetic effects were modeled by
considering the activation of the β -adrenergic signaling cas-
cade by Iso through protein kinase A-dependent phosphory-
lation of cellular substrates, as proposed in [12]. Specifically,
the maximum conductances of the L-type calcium current
(gCaL) and of the slow delayed rectifier potassium current
(gKs) were increased by 250% and 58%, respectively, and
the maximum conductance of the transient outward current
(gto) was reduced by 38% to simulate the effects of 1 µM
Iso.
The effect of blocking SK channels was additionally
tested. The Skibsbye model already included a description
for the ISK current [8]. Since Courtemanche S and R mod-
els did not include the ISK current, it was introduced by
following the formulation developed by Engel et al [13]
for neurons, with its conductance gSK updated to match
the experimentally observed 20% increase in APD after ISK
block in atrial myocytes from sinus rhythm patients [4].
B. Human atrial tissue models
Square tissues of 5x5 cm with a longitudinal conductivity
of 0.004 S/cm and a transversal-to-longitudinal conductivity
ratio of 0.5 were considered. Since combined SK block
and Iso rendered qualitatively similar results in the three
analyzed AP models, results in tissue are only presented
for the Courtemanche S model. Both a homogeneous spatial
ACh distribution and a heterogeneous ACh distribution with
circular patches of 1 cm radius were tested.
C. Simulation protocols
Cell and tissue simulations were run with a temporal
resolution of 0.005 ms. For tissue simulations, a space step
of 0.02 cm was considered.
ACh concentrations of 0, 0.001, 0.01, 0.1 and 1 µM
were tested to cover values below and above the reported
physiological range of 0.01–0.1 µM [14]. In tissue, only the
maximal physiological dose of 0.1 µM was investigated.
Individual and combined effects of SK channel block
and Iso were tested on top of ACh. In tissue, SK block
and Iso were considered as uniformly applied all over the
tissue, independently of whether ACh was homogeneously
or heterogeneously distributed.
To reach steady state, single cells were paced at a fixed
cycle length (CL) of 1000 ms for 1 minute. The values
of the models’ state variables at steady-state were used to
initialize tissue simulations. APD90 was measured at 90%
AP repolarization. Activation time (AT) was computed as the
time instant associated with maximum UV during phase zero
of each AP, while total activation time (TAT) was computed
as the time lapse between the first and last activation across
the tissue.
Cellular simulations were performed using MATLAB
while tissue simulations were performed with ELECTRA,
an in-house software implementing the Finite Element and
Meshfree Mixed Collocation methods for the solution of the
monodomain model. In this work we used the Finite Element
implementation.
III. RESULTS
A. Parasympathetic, sympathetic and SK channel block ef-
fects in single cells
ACh slowed down the UV of the AP and shortened the
APD in a dose dependant manner, as shown in Fig. 1 and Fig.
2. In particular, 0.1 µM ACh reduced the UV by 5.2% in the
Courtemanche S and R models and by 5.0% in the Skibsbye
model. Additionally, 0.1 µM ACh shortened the APD90 by
36.2% in Courtemanche S, by 25.01% in Courtemanche R
and by 41.7% in Skibsbye models.
Sympathetic stimulation by 1 µM Iso was highly de-
pendent on the AP shape. For Courtemanche models, Iso
shortened APD90 by 25.1% in the S model and by 23.9% in
the R model. For the Skibsbye model, APD90 was slightly
prolonged by Iso. This variability in the AP response to Iso is
in line with reported experimental evidence, some of which
point out to APD90 prolongation [12], whereas others report
APD90 shortening [16].
Fig. 1 and Fig. 2 show the results for individual and
combined effects of SK channel block and Iso on top
of ACh. Regarding SK block, it could be observed that,
for physiologically moderate ACh doses (0.01 muM), ISK
block was able to completely counteract the effects of ACh.
For higher physiological ACh doses (0.1 µM ACh), the
effects were less prominent, particularly for Skibsbye and
Courtemanche S models, where SK block only prolonged
APD90 by 28.57% and 19.48% of the APD reduction caused
by ACh (Fig. 2 (c) and (a)).
Results for adrenergic stimulation on top of ACh exhibited
a strong model dependence. In the case of the Skibsbye
model, 1 µM Iso was able to attenuate the effects of
parasympathetic stimulation, while in both Courtemanche
variants Iso caused further APD90 shortening.
The combination of SK block and 1 µM Iso counteracted
ACh effects in all cases. For the maximal physiological ACh
dose of 0.1 µM, the combined action led to a recovery
of baseline APD90, with prolongation being 92% of the
the ACh-induced APD90 shortening for Skibsbye, 120% for
Courtemanche R and 82.6% for Courtemanche S models.
Fig. 1. Simulated APs at baseline and under 0.1 µM ACh, individually
and in combination with 1 µM Iso and/or SK channel block on human
atrial cardiomyocytes paced at a CL of 1000 ms, for Courtemanche S (a),
Courtemanche R (b) and Skybsbye (c) AP models.
B. Parasympathetic, sympathetic and SK channel block ef-
fects in tissue
ACh concentration of 0.1 µM slowed down the propaga-
tion of the electrical wavefront in tissue, slightly increasing
TAT by 4 ms for homogeneous ACh distribution and by
2 ms for heterogeneous ACh distribution. The mean lon-
gitudinal CV decreased from 97.2 cm/s to 89.3 cm/s for
homogeneous ACh, which is in agreement with experimental
results [10]. Interventions involving SK channel block, Iso
or the combination of the two did not modify the reduced
CV induced by ACh, with TAT values remaining the same
as under ACh, both when ACh was considered as distributed
homogeneously and heterogeneously in the tissue.
Results in terms of APD90 were, however, remarkably
altered by all tested interventions. While mean APD90 across
the tissue was 244.26 ms at baseline, such value was
shortened by 110.74 ms when ACh was homogeneously
added. SK block on top of ACh prolonged mean APD90 by
67.35 ms, while Iso had the opposite effect, causing further
shortening by 18.22 ms. The combination of Iso and SK
block was able to prolong mean APD and restore it to a value
of 200.86 ms. The corresponding results for heterogeneous
ACh distribution are presented in Fig. 3 (a), which shows
APD90 maps for baseline, heterogeneous ACh as well as
individual and combined SK block and Iso on top of ACh.
Fig. 3 (b) summarizes median, lower and upper quartiles
of APD90 values. As can be observed from the figures, the
heterogeneous addition of ACh shortened mean APD by
58.01 ms. SK channel block on top of ACh prolonged mean
APD90 by 33.06 ms while Iso caused further shortening by
45.64 ms. As in the homogeneous case, the combination of
Fig. 2. APD90 vs ACh dose for human atrial myocytes paced at a CL of
1000 ms at baseline and under ACh, individually and in combination with 1
µM Iso and/or SK channel block, for Courtemanche S (a), Courtemanche
R (b) and Skybsbye (c) AP models.
Iso and SK block was able to prolong the mean APD and
restore it to a value of 236.6 ms, which is very close to the
baseline value.
IV. DISCUSSION AND CONCLUSION
This study has investigated the effects of SK channel
inhibition and adrenergic stimulation on parasympathetically
stimulated human atrial cardiomyocytes and tissue. For
myocytes under physiological ACh doses, ISK inhibition
showed the ability to antagonize parasympathetic effects,
whereas the effects of Iso were highly dependent on the AP
shape, in agreement with experimental results. Combined SK
block and Iso were in any case able to revert ACh effects,
prolonging APD90 to values close to baseline levels. At the
tissue level, the combination of Iso and SK block did not
have any remarkable effects on CV, but, similarly to the cell
level, it was able to bring mean APD90 back to baseline
values.
This study focused on patients in sinus rhythm, where
the SK current has been reported to be more highly ex-
pressed than in AF remodelling [17]. Future investigations
could expand this research to assess SK channel inhibition
effects on remodeled atrial tissues representative of chronic
AF patients. Additional characterizations on the ability of
SK channel inhibition and adrenergic stimulation to revert
arrhythmogenic behaviors induced by ACh could be under-
taken in further studies, e.g. aimed at testing the capacity of
such interventions to stop reentrant activity [18].
In conclusion, the results from this study support SK
channel block, in combination with adrenergic stimulation,
as an option to counteract potential arrhythmogenic effects of
Fig. 3. APD90 maps (a) and violin plots (b) at baseline and under ACh, individually and in combination with 1 µM Iso and/or SK channel block, for
APs defined by the Courtemanche S model. In the violin plots, black lines represent the mean APD90 while red ones, the median APD90.
parasympathetic stimulation in human atria, even if further
investigations are needed to confirm this statement.
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